209 related articles for article (PubMed ID: 19131934)
1. Podocyte loss in human hypertensive nephrosclerosis.
Wang G; Lai FM; Kwan BC; Lai KB; Chow KM; Li PK; Szeto CC
Am J Hypertens; 2009 Mar; 22(3):300-6. PubMed ID: 19131934
[TBL] [Abstract][Full Text] [Related]
2. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
[TBL] [Abstract][Full Text] [Related]
3. Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis.
Wang G; Kwan BC; Lai FM; Choi PC; Chow KM; Li PK; Szeto CC
Am J Hypertens; 2010 Jan; 23(1):78-84. PubMed ID: 19910931
[TBL] [Abstract][Full Text] [Related]
4. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.
Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC
Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726
[TBL] [Abstract][Full Text] [Related]
5. Expression of ACE and ACE2 in patients with hypertensive nephrosclerosis.
Wang G; Lai FM; Kwan BC; Lai KB; Chow KM; Li PK; Szeto CC
Kidney Blood Press Res; 2011; 34(3):141-9. PubMed ID: 21346373
[TBL] [Abstract][Full Text] [Related]
6. Glomerular Density in Biopsy-Proven Hypertensive Nephrosclerosis.
Haruhara K; Tsuboi N; Kanzaki G; Koike K; Suyama M; Shimizu A; Miyazaki Y; Kawamura T; Ogura M; Yokoo T
Am J Hypertens; 2015 Sep; 28(9):1164-71. PubMed ID: 25631380
[TBL] [Abstract][Full Text] [Related]
7. Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race.
Hughson MD; Puelles VG; Hoy WE; Douglas-Denton RN; Mott SA; Bertram JF
Nephrol Dial Transplant; 2014 Jul; 29(7):1399-409. PubMed ID: 24327566
[TBL] [Abstract][Full Text] [Related]
8. Urine podocyte mRNAs mark progression of renal disease.
Sato Y; Wharram BL; Lee SK; Wickman L; Goyal M; Venkatareddy M; Chang JW; Wiggins JE; Lienczewski C; Kretzler M; Wiggins RC
J Am Soc Nephrol; 2009 May; 20(5):1041-52. PubMed ID: 19389856
[TBL] [Abstract][Full Text] [Related]
9. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
Fukuda A; Sato Y; Iwakiri T; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757
[TBL] [Abstract][Full Text] [Related]
10. Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker.
Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li PK; Szeto CC
Eur J Endocrinol; 2008 Mar; 158(3):317-22. PubMed ID: 18299464
[TBL] [Abstract][Full Text] [Related]
11. Expression of podocyte-associated molecules in acquired human kidney diseases.
Koop K; Eikmans M; Baelde HJ; Kawachi H; De Heer E; Paul LC; Bruijn JA
J Am Soc Nephrol; 2003 Aug; 14(8):2063-71. PubMed ID: 12874460
[TBL] [Abstract][Full Text] [Related]
12. The effect of connective tissue growth factor on renal fibrosis and podocyte injury in hypertensive rats.
Lu W; Liu S; Zhao Z; Liu Y; Li T
Ren Fail; 2014 Oct; 36(9):1420-7. PubMed ID: 25003484
[TBL] [Abstract][Full Text] [Related]
13. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases.
Szeto CC; Lai KB; Chow KM; Szeto CY; Yip TW; Woo KS; Li PK; Lai FM
Clin Chim Acta; 2005 Nov; 361(1-2):182-90. PubMed ID: 15996647
[TBL] [Abstract][Full Text] [Related]
14. Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases?
Lopes TG; de Souza ML; da Silva VD; Dos Santos M; da Silva WIC; Itaquy TP; Garbin HI; Veronese FV
PLoS One; 2019; 14(6):e0217585. PubMed ID: 31220088
[TBL] [Abstract][Full Text] [Related]
15. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
16. Amplified Association Between Blood Pressure and Albuminuria in Overweight Patients With Biopsy-Proven Hypertensive Nephrosclerosis.
Kohagura K; Furuichi K; Kochi M; Shimizu M; Yuzawa Y; Hara A; Toyama T; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ubara Y; Hoshino J; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Ogawa D; Mise K; Shibagaki Y; Kimura K; Haneda M; Makino H; Matsuo S; Wada T;
Am J Hypertens; 2019 Apr; 32(5):486-491. PubMed ID: 30689693
[TBL] [Abstract][Full Text] [Related]
17. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES
Nephron; 2015; 131(1):34-42. PubMed ID: 26340089
[TBL] [Abstract][Full Text] [Related]
18. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.
Liang S; Le W; Liang D; Chen H; Xu F; Chen H; Liu Z; Zeng C
BMC Nephrol; 2016 Apr; 17():42. PubMed ID: 27066888
[TBL] [Abstract][Full Text] [Related]
19. Synthetic/secreting and apoptotic phenotypes in renal biopsy tissues from hypertensive nephrosclerosis patients.
Kimura N; Yonemoto S; Machiguchi T; Li X; Kimura H; Yoshida H
Hypertens Res; 2006 Aug; 29(8):573-80. PubMed ID: 17137212
[TBL] [Abstract][Full Text] [Related]
20. Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis.
Wang G; Lai FM; Tam LS; Li KM; Lai KB; Chow KM; Li KT; Szeto CC
J Rheumatol; 2007 Dec; 34(12):2358-64. PubMed ID: 17985404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
